UoA 3 Allied Health Professions, Dentistry, Nursing and Pharmacy

The Unit’s world-leading interdisciplinary research is ranked 4th in the UK with a GPA of 3.42. Impacts delivered through the research are far-reaching and varied in nature ranging from the introduction of new therapies and diagnostics, leading change in practice guidelines and standards, through to advancing and informing public-body policy initiatives. 100% of our research environment was rated as conducive to producing research of world-leading quality in terms of its vitality and sustainability. 90% of our research has been deemed ‘outstanding’ for its impact in terms of its reach and significance.

Quality level 4 3 2 1 UC
Overall 48.0% 46.0% 6.0% 0.0% 0.0%
Outputs 23.1% 67.2% 9.7% 0.0% 0.0%
Impact 90.0% 10.0% 0.0% 0.0% 0.0%
Environment 100.0% 0.0% 0.0% 0.0% 0.0%
About the REF

The 'Allied Health' Unit of Assessment lies within the College of Biomedical and Life Sciences. The unit comprises researchers from groups which are aligned in most cases to Academic Schools: Dentistry; Healthcare Sciences; Medicine (Institute of Molecular and Experimental Medicine); Optometry and Vision Sciences, and Pharmacy and Pharmaceutical Sciences.

Strategy is focused on delivering world-leading discoveries and healthcare benefits for human health and welfare. We build research capacity and culture by investing in facilities and staff.

Research infrastructure has benefitted from investments totalling £28m from a range of sources including direct University capital, HEFCW and others. Relocation to new purpose-built facilities (£20M) has accommodated preclinical and clinical research, and six new professorial staff enhance our research leadership.

Main achievements during the REF period include research awards totalling £60m and an income ('spend') of £41m during the assessment period - a 40% increase compared to the combined spend of the same research groups during RAE 2008.

Case studies

Down's Syndrome Vision Research Unit

A clearer view for children with Down's Syndrome

Improving educational opportunities and eye care for children with Down’s syndrome.

Two police officers

Reducing violent crime

We are reducing violence through research, new use of data and original collaborations between medicine and criminal justice.

Pills in a bottle image

Discovering the world's most powerful antiviral agent against shingles

FV-100 is a brand new anti-viral drug that aims to bring relief to millions of shingle sufferers from around the world.

Scientist examining liquid in lab

Creating new anti-viral and cancer drugs

ProTide technology is a pro-drug strategy with proven capacity to generate new drug candidates for nucleoside-based antiviral and anti-cancer indications.

Research areas

Research is interdisciplinary spanning the full translational spectrum across three overlapping spheres of operation:-

Spheres of operationScope
Molecular to systems-level preclinical researchAddresses mechanisms of disease, therapeutic targets and interventions (e.g. drugs, diagnostics, tissue regeneration) in a range of disease areas (dental, cancer, cardiovascular, endocrine, infection, musculoskeletal, neurological, ocular).
Clinical researchIntegrates with the Unit's pre-clinical studies, e.g. new drug candidates, but can also be conducted independent of pre-clinical research, e.g. clinical rehabilitation research. Clinical studies are conducted both within the Unit accessing particular patient cohorts, e.g. chronic non-healing wounds, low vision special needs patients, or in conjunction with the NHS e.g. dental clinics, or externally with partners e.g. drug trials.
Public health/healthcare delivery researchAddresses epidemiological, quality of life, pharmacoeconomics, workforce and practice-based investigations.

Research centres and groups

Centre/GroupSummary
Arthritis Research UK Biomechanics and Bioengineering Centre (ARUKBBC)Promotes collaborations between biomedical scientists and practitioners.
European Cancer Stem Cell Research InstituteImproving our understanding of the role of cancer stem cells in a range of cancers, through world-leading research.
Neuroscience and Mental Health Research InstituteTaking new discoveries and translating them into greater understanding and diagnosis of mental illness.
 

Overall ranking

Pos. Institution GPA
1University of Sheffield B3.51
2Swansea University A3.49
3University of Southampton3.47
4Cardiff University3.42
4University of Nottingham A3.42
6University of Bath3.41
7University of Manchester3.38
8University of Surrey3.37
8Aston University3.37
10Queen's University of Belfast A3.36

Table continues to 94